Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Red miso, a fermented soybean paste commonly used in Japanese cuisine, has been investigated in scientific studies for its potential health benefits, including effects on metabolic syndrome—a cluster of conditions such as obesity, hypertension, dyslipidemia, and insulin resistance. Some animal studies and limited human observational studies suggest that fermented soy products like red miso may positively influence components of metabolic syndrome. This is thought to be due to the presence of bioactive compounds produced during fermentation, such as isoflavones, peptides, and probiotics, which might help improve lipid profiles, reduce blood pressure, and enhance insulin sensitivity. For example, a few small-scale studies have reported improvements in blood pressure and cholesterol levels with regular miso consumption. However, rigorous clinical trials specifically evaluating red miso’s effects on metabolic syndrome as a whole are lacking, and results are sometimes confounded by high sodium content, which can have adverse cardiovascular effects in susceptible populations. While traditional use of miso is more oriented toward general health rather than targeted treatment of metabolic syndrome, the available scientific evidence supporting its use for this condition is preliminary and not robust. Overall, red miso shows some promise based on early data, but more well-designed human studies are needed to confirm any specific benefits for metabolic syndrome.

More about Red miso
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Red miso

Products containing Red miso